IAIM
RXRX icon

International Assets Investment Management’s Recursion Pharmaceuticals RXRX Stock Holding History

International Assets Investment Management’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.5K Sell
6,143
-1,778
-22% -$5.92K ﹤0.01% 1570
2026
Q1 		$24.2K Buy
7,921
+312
+4% +$1.21K ﹤0.01% 1450
2025
Q4 		$31.1K Buy
+7,609
New +$37.7K ﹤0.01% 1350
2025
Q1 		– Sell
-11,969
Closed -$86.3K – 862
2024
Q4 		$86.3K Sell
11,969
-72,713
-86% -$489K 0.01% 792
2024
Q3 		$12.8K Buy
84,682
+71,182
+527% +$510K 0.04% 371
2024
Q2 		$101K Buy
+13,500
New +$118K 0.01% 942

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
IEFM
IQ EQ Fund Management Dublin 2, Ireland $1.57B AUM 40.42% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

International Assets Investment Management's RXRX Position: Q2 2026 in Review

International Assets Investment Management reduced its Recursion Pharmaceuticals (RXRX) stake by 22% in Q2 2026, selling an estimated $5.92K and leaving 6,143 shares worth $22.5K. The position accounts for ﹤0.01% of the portfolio, ranked #1570.

International Assets Investment Management first reported a position in RXRX in Q2 2024 and has held it in 6 quarters since. The position peaked at $101K in Q2 2024. 218 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • International Assets Investment Management held 6,143 shares of Recursion Pharmaceuticals worth $22.5K as of Q2 2026.
  • International Assets Investment Management sold 1,778 Recursion Pharmaceuticals shares in Q2 2026, an estimated $5.92K.
  • Recursion Pharmaceuticals made up ﹤0.01% of International Assets Investment Management's portfolio in Q2 2026, its #1570 holding.
  • International Assets Investment Management first reported a position in Recursion Pharmaceuticals in Q2 2024 and has held it in 6 quarters since.
  • International Assets Investment Management's Recursion Pharmaceuticals position peaked at $101K in Q2 2024.
  • 218 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on International Assets Investment Management's 13F filing for Q2 2026, filed 22 Jul 2026.